Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery.
Sign Up to like & getrecommendations! Published in 2017 at "Tuberculosis"
DOI: 10.1016/j.tube.2017.06.004
Abstract: Management of tuberculosis, already a global health emergency, is becoming increasingly challenging with extensive misuse of second line drugs and their inaccessibility to eighty percent of the eligible patients. Rising statistics of antimicrobial resistance underscores… read more here.
Keywords: anti mycobacterial; enabling faster; discovery; decisions secondary ... See more keywords